JP2014518609A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518609A5
JP2014518609A5 JP2013556902A JP2013556902A JP2014518609A5 JP 2014518609 A5 JP2014518609 A5 JP 2014518609A5 JP 2013556902 A JP2013556902 A JP 2013556902A JP 2013556902 A JP2013556902 A JP 2013556902A JP 2014518609 A5 JP2014518609 A5 JP 2014518609A5
Authority
JP
Japan
Prior art keywords
dietary supplement
derivative
supplement according
derivatives
parumitoreato
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013556902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518609A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/027489 external-priority patent/WO2012119078A2/en
Publication of JP2014518609A publication Critical patent/JP2014518609A/ja
Publication of JP2014518609A5 publication Critical patent/JP2014518609A5/ja
Pending legal-status Critical Current

Links

JP2013556902A 2011-03-03 2012-03-02 C16:1n7−パルミトレアートを含む組成物および方法 Pending JP2014518609A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161449015P 2011-03-03 2011-03-03
US61/449,015 2011-03-03
PCT/US2012/027489 WO2012119078A2 (en) 2011-03-03 2012-03-02 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015222558A Division JP6267681B2 (ja) 2011-03-03 2015-11-13 C16:1n7−パルミトレアートを含む組成物および方法

Publications (2)

Publication Number Publication Date
JP2014518609A JP2014518609A (ja) 2014-08-07
JP2014518609A5 true JP2014518609A5 (enExample) 2015-01-29

Family

ID=46753682

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013556902A Pending JP2014518609A (ja) 2011-03-03 2012-03-02 C16:1n7−パルミトレアートを含む組成物および方法
JP2015222558A Active JP6267681B2 (ja) 2011-03-03 2015-11-13 C16:1n7−パルミトレアートを含む組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015222558A Active JP6267681B2 (ja) 2011-03-03 2015-11-13 C16:1n7−パルミトレアートを含む組成物および方法

Country Status (10)

Country Link
US (6) US8703818B2 (enExample)
EP (2) EP3510998A1 (enExample)
JP (2) JP2014518609A (enExample)
KR (1) KR20140010126A (enExample)
CN (1) CN103889219A (enExample)
AU (5) AU2012223171B2 (enExample)
CA (1) CA2829051C (enExample)
MX (1) MX2013010076A (enExample)
SG (1) SG193258A1 (enExample)
WO (1) WO2012119078A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101942B2 (en) 2009-06-16 2015-08-11 Aurora Algae, Inc. Clarification of suspensions
US9200236B2 (en) 2011-11-17 2015-12-01 Heliae Development, Llc Omega 7 rich compositions and methods of isolating omega 7 fatty acids
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9266973B2 (en) 2013-03-15 2016-02-23 Aurora Algae, Inc. Systems and methods for utilizing and recovering chitosan to process biological material
US20140275613A1 (en) * 2013-03-15 2014-09-18 Aurora Algae, Inc. Conversion of free fatty acids to ethyl esters
WO2015077499A1 (en) 2013-11-22 2015-05-28 Heliae Development, Llc Isolation of omega-7 fatty acid ethyl esters from natural oils
KR102243022B1 (ko) * 2014-03-05 2021-04-21 삼성메디슨 주식회사 선택 정보에 기초하여 관심 영역에 포함된 혈류에 대한 정보를 출력하는 방법, 장치 및 시스템.
WO2015187997A1 (en) 2014-06-04 2015-12-10 Tersus Pharmaceuticals, LLC METHODS OF TREATING CHRONIC DRY EYE DISEASE USING C16:1n7 PALMITOLEATE AND DERIVATIVES THEREOF
EP3166415A4 (en) * 2014-07-08 2017-12-06 Omega Protein Corporation Enrichment of palmitoleic acid palmitoleic acid derivatives by dry and solvent-aided winterization
WO2016011410A1 (en) * 2014-07-17 2016-01-21 Cornell University Omega-3 fatty acid enrichment of poultry products with defatted microalgae animal feed
CA2963980A1 (en) * 2014-10-15 2016-04-21 Burke & Boyer Nyc Monounsaturated fatty acid compositions and use for treating atherosclerosis
US10058524B2 (en) 2015-02-18 2018-08-28 Tersus Life Sciences, LLC Methods for improving joint function
IT201600093741A1 (it) * 2016-09-19 2018-03-19 Codex V Srl Insaponificabili di lipidi naturali per l’uso nel trattamento di patologie cardiache
TWI750189B (zh) 2016-12-15 2021-12-21 大陸商深圳瑞健生命科學研究院有限公司 一種治療冠狀動脈粥樣硬化及其併發症的方法
CN108210904A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 治疗动脉粥样硬化及其并发症的药物及其用途
JP7168990B2 (ja) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド 肥満症を予防および治療するための方法および薬物
AU2022248850A1 (en) 2021-03-27 2023-11-09 TRx Biosciences Limited Compositions having improved bioavailability of therapeutics
JP2026011459A (ja) * 2024-07-11 2026-01-23 日油株式会社 パルミトレイン酸を含有する脂肪酸組成物

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
JPS61297A (ja) 1984-06-12 1986-01-06 日本油脂株式会社 オレイン酸の製造法
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
CA1283827C (en) 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5198250A (en) 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5298637A (en) * 1992-10-22 1994-03-29 Arco Chemical Technology, L.P. Process for producing a reduced calorie lipid composition
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
DE60024401T2 (de) * 1999-12-10 2006-08-03 Loders Croklaan B.V. Palmitoleinsäure und ihre Verwendung in Lebensmitteln
EP1106072B1 (en) 1999-12-10 2005-11-30 Loders Croklaan B.V. Palmitoleic acid and its use in foods
US20030064950A1 (en) * 2001-02-23 2003-04-03 Ntambi James M. Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity
US6686185B1 (en) * 2000-03-07 2004-02-03 Millennium Pharmaceuticals, Inc. 25934, a novel fatty acid desaturase and uses therefor
AT414205B (de) * 2000-06-20 2006-10-15 Vis Vitalis Lizenz & Handels Verfahren zur herstellung von ungesättigtem fettsäure-trockenkonzentrat
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
US20050004218A1 (en) * 2003-05-05 2005-01-06 Bauman Dale E. Vaccenic acid
EP1729851A2 (en) * 2004-03-10 2006-12-13 Natural ASA Compositions comprising reverse isomers of conjugated linoleic acid
JP4931391B2 (ja) * 2004-10-08 2012-05-16 日清オイリオグループ株式会社 不飽和脂肪酸濃縮物の製造方法
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
ES2285923B1 (es) 2005-12-14 2008-10-16 Dieta Mediterranea Aceites Y Vinagres, S.A. Producto para su utilizacion en la prevencion y tratamiento de enfermedades cardiovasculares, cancer y enfermedades inflamatorias cronicas.
US20100242345A1 (en) 2006-05-19 2010-09-30 LS9, Inc Production of fatty acids & derivatives thereof
US8110670B2 (en) 2006-05-19 2012-02-07 Ls9, Inc. Enhanced production of fatty acid derivatives
JP2008156296A (ja) * 2006-12-25 2008-07-10 Sapporo Breweries Ltd メタボリックシンドローム改善剤
US8110093B2 (en) 2007-03-14 2012-02-07 Ls9, Inc. Process for producing low molecular weight hydrocarbons from renewable resources
US20080293060A1 (en) 2007-04-23 2008-11-27 Ls9, Inc. Methods and Compositions for Identification of Hydrocarbon Response, Transport and Biosynthesis Genes
JP5912251B2 (ja) 2007-05-22 2016-06-01 アールイージー ライフ サイエンシズ リミテッド ライアビリティ カンパニー 炭化水素産生遺伝子およびその使用方法
WO2009009391A2 (en) 2007-07-06 2009-01-15 Ls9, Inc. Systems and methods for the production of fatty esters
WO2009039505A1 (en) * 2007-09-20 2009-03-26 Rutgers, The State University Of New Jersey Compositions and methods for treating cardiovascular conditions
DK2280928T3 (en) * 2008-05-01 2018-11-05 Complexa Inc Vinyl-substituted fatty acids
CN101278743B (zh) * 2008-05-08 2012-01-25 浙江大学城市学院 一种从蚕蛹中提取不饱和脂肪酸的方法
JP2011522525A (ja) 2008-05-16 2011-08-04 エルエス9・インコーポレイテッド 炭化水素を製造するための方法および組成物
WO2010021711A1 (en) 2008-08-18 2010-02-25 Ls9, Inc. Systems and methods for the production of mixed fatty esters
WO2010028336A2 (en) 2008-09-08 2010-03-11 President And Fellows Of Harvard College Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
WO2010062480A2 (en) 2008-10-28 2010-06-03 Ls9, Inc. Methods and compositions for producing fatty alcohols
PT2349250T (pt) * 2008-10-31 2017-07-25 Lipid Pharmaceuticals Ehf Ácidos gordos para uso como um medicamento
WO2010118362A1 (en) * 2009-04-09 2010-10-14 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for inducing physiological hypertrophy
CA2758298A1 (en) 2009-04-10 2010-10-14 Ls9, Inc. Production of commercial biodiesel from genetically modified microorganisms
BRPI1015313B1 (pt) 2009-04-27 2021-06-01 Genomatica, Inc. Método fermentativo para produzir um éster de ácido graxo empregando um microorganismo geneticamente modificado e método para a produção de ésteres de ácidos graxos

Similar Documents

Publication Publication Date Title
HRP20200065T1 (hr) Upotreba etilnog estera ikozapentaenske kiseline u liječenju hipertrigliceridemije
RU2014138996A (ru) Гормонсодержащая эмульсия
ES2634490T3 (es) Derivados de ácido napht-2-ylacetico para tratar el sida
JP2008540394A5 (enExample)
JP2014509655A5 (enExample)
HRP20171431T1 (hr) Terapijska parenteralna primjena krilovog ulja
JP2015527333A5 (enExample)
JP2014517028A5 (enExample)
JP2014525916A5 (enExample)
PH12015500930B1 (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
WO2013153071A3 (en) A nutritional composition
JP2010195825A5 (enExample)
JP2012502090A5 (enExample)
NZ727980A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EA201690483A1 (ru) Композиция среднецепочечных жирных кислот и корм с добавлением композиции
HRP20160203T1 (hr) Pripravci koji sadrže 15-hepe i postupci njihove upotrebe
JP2013082950A5 (enExample)
PH12014500510A1 (en) Use of omega fatty acids for treating disease
JP2014528494A5 (enExample)
JP2020182497A5 (enExample)
JP2015518469A5 (enExample)
RU2016115985A (ru) Лактоферрин для лечения ibd, вызванного бактериальной инвазией
WO2010004579A3 (en) Orally active curcuminoid compounds
Lança et al. Can muscle fatty acid signature be used to distinguish diets during the marine trophic phase of sea lamprey (Petromyzon marinus, L.)?
WO2014008379A3 (en) Diamine and meglumine salt forms of fatty acids